SAFC-Jerusalem Prays $30 Million CMO Expansion Investment Pays Off in Attracting More High-Potency APIs Clients

SAFC-Jerusalem Prays $30 Million CMO Expansion Investment Pays Off in Attracting More High-Potency APIs Clients

SAFC-Jerusalem Prays $30 Million CMO Expansion Investment Pays Off in Attracting More High-Potency APIs Clients

SUGAR LAND--October 12, 2010--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Mention the ancient city of Jerusalem, Israel, and the religious overtones of the city tend to come to mind. While fully acknowledging the sanctity of its historical significance, it would be remiss to ignore the fact that the city has a place in the high-tech secular world of the 21st century Pharmaceutical Industry. Case in point--SAFC-Jerusalem (Jerusalem), a division of Sigma-Aldrich Corporation (NASDAQ:SIAL) (St. Louis, Missouri) has just completed a $30 million investment to expand its contract manufacturing (CMO) facility in Jerusalem (source: Industrial Info's Pharmaceutical Tracker - Online Database).

Subscribe Now!(All Fields Required)

Standard Membership - Free